BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33864122)

  • 1. Potassium Channels in Cancer.
    Ganser K; Klumpp L; Bischof H; Lukowski R; Eckert F; Huber SM
    Handb Exp Pharmacol; 2021; 267():253-275. PubMed ID: 33864122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion Transport and Radioresistance.
    Roth B; Huber SM
    Rev Physiol Biochem Pharmacol; 2022; 183():217-249. PubMed ID: 32737751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment.
    Andersen AP; Moreira JM; Pedersen SF
    Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130098. PubMed ID: 24493746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes: Critical Mediators of Tumour Microenvironment Reprogramming.
    Malla RR; Shailender G; Kamal MA
    Curr Med Chem; 2021; 28(39):8182-8202. PubMed ID: 33334279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncochannels.
    Huber SM
    Cell Calcium; 2013 Apr; 53(4):241-55. PubMed ID: 23357407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles for Ca
    Girault A; Ahidouch A; Ouadid-Ahidouch H
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118644. PubMed ID: 31931022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca
    Audero MM; Prevarskaya N; Fiorio Pla A
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channels, tumorigenesis and targeted drugs.
    Xia C; Liu C; Ren S; Cai Y; Zhang Q; Xia C
    Biomed Pharmacother; 2023 Jun; 162():114673. PubMed ID: 37031494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K
    Stegen B; Klumpp L; Misovic M; Edalat L; Eckert M; Klumpp D; Ruth P; Huber SM
    Eur Biophys J; 2016 Oct; 45(7):585-598. PubMed ID: 27165704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroitin Sulphate Proteoglycans in the Tumour Microenvironment.
    Mellai M; Casalone C; Corona C; Crociara P; Favole A; Cassoni P; Schiffer D; Boldorini R
    Adv Exp Med Biol; 2020; 1272():73-92. PubMed ID: 32845503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
    Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanical microenvironment in cancer: How physics affects tumours.
    Nagelkerke A; Bussink J; Rowan AE; Span PN
    Semin Cancer Biol; 2015 Dec; 35():62-70. PubMed ID: 26343578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining a metabolic landscape of tumours: genome meets metabolism.
    Seth Nanda C; Venkateswaran SV; Patani N; Yuneva M
    Br J Cancer; 2020 Jan; 122(2):136-149. PubMed ID: 31819196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy and Tumour Chemotherapy.
    Hou X; Jiang J; Tian Z; Wei L
    Adv Exp Med Biol; 2020; 1207():351-374. PubMed ID: 32671759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channels activity unveils cancer vulnerability.
    Eskandari N; Gentile S
    Curr Top Membr; 2023; 92():1-14. PubMed ID: 38007264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron and cancer: more ore to be mined.
    Torti SV; Torti FM
    Nat Rev Cancer; 2013 May; 13(5):342-55. PubMed ID: 23594855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channels are a new target field in anticancer drug design.
    Villalonga N; Ferreres JC; Argilés JM; Condom E; Felipe A
    Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):212-23. PubMed ID: 18221064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.